196 related articles for article (PubMed ID: 21732131)
1. Subcellular FIH-1 expression patterns in invasive breast cancer in relation to HIF-1α expression.
Hyseni A; van der Groep P; van der Wall E; van Diest PJ
Cell Oncol (Dordr); 2011 Dec; 34(6):565-70. PubMed ID: 21732131
[TBL] [Abstract][Full Text] [Related]
2. Cytoplasmic location of factor-inhibiting hypoxia-inducible factor is associated with an enhanced hypoxic response and a shorter survival in invasive breast cancer.
Tan EY; Campo L; Han C; Turley H; Pezzella F; Gatter KC; Harris AL; Fox SB
Breast Cancer Res; 2007; 9(6):R89. PubMed ID: 18096060
[TBL] [Abstract][Full Text] [Related]
3. Differential prognostic impact of hypoxia induced and diffuse HIF-1alpha expression in invasive breast cancer.
Vleugel MM; Greijer AE; Shvarts A; van der Groep P; van Berkel M; Aarbodem Y; van Tinteren H; Harris AL; van Diest PJ; van der Wall E
J Clin Pathol; 2005 Feb; 58(2):172-7. PubMed ID: 15677538
[TBL] [Abstract][Full Text] [Related]
4. p300 and p53 levels determine activation of HIF-1 downstream targets in invasive breast cancer.
Vleugel MM; Shvarts D; van der Wall E; van Diest PJ
Hum Pathol; 2006 Aug; 37(8):1085-92. PubMed ID: 16867872
[TBL] [Abstract][Full Text] [Related]
5. The key hypoxia regulated gene CAIX is upregulated in basal-like breast tumours and is associated with resistance to chemotherapy.
Tan EY; Yan M; Campo L; Han C; Takano E; Turley H; Candiloro I; Pezzella F; Gatter KC; Millar EK; O'Toole SA; McNeil CM; Crea P; Segara D; Sutherland RL; Harris AL; Fox SB
Br J Cancer; 2009 Jan; 100(2):405-11. PubMed ID: 19165203
[TBL] [Abstract][Full Text] [Related]
6. Inhibitor of nuclear factor-kappaB alpha derepresses hypoxia-inducible factor-1 during moderate hypoxia by sequestering factor inhibiting hypoxia-inducible factor from hypoxia-inducible factor 1alpha.
Shin DH; Li SH; Yang SW; Lee BL; Lee MK; Park JW
FEBS J; 2009 Jul; 276(13):3470-80. PubMed ID: 19456861
[TBL] [Abstract][Full Text] [Related]
7. Featured Article: Hypoxia-inducible factor-1α dependent nuclear entry of factor inhibiting HIF-1.
Liang K; Ding XQ; Lin C; Kang YJ
Exp Biol Med (Maywood); 2015 Nov; 240(11):1446-51. PubMed ID: 25687434
[TBL] [Abstract][Full Text] [Related]
8. BRCA1 tumours correlate with a HIF-1alpha phenotype and have a poor prognosis through modulation of hydroxylase enzyme profile expression.
Yan M; Rayoo M; Takano EA; ; Fox SB
Br J Cancer; 2009 Oct; 101(7):1168-74. PubMed ID: 19724277
[TBL] [Abstract][Full Text] [Related]
9. Necrosis related HIF-1alpha expression predicts prognosis in patients with endometrioid endometrial carcinoma.
Seeber LM; Horrée N; van der Groep P; van der Wall E; Verheijen RH; van Diest PJ
BMC Cancer; 2010 Jun; 10():307. PubMed ID: 20565904
[TBL] [Abstract][Full Text] [Related]
10. DNA methylation analysis of the HIF-1α prolyl hydroxylase domain genes PHD1, PHD2, PHD3 and the factor inhibiting HIF gene FIH in invasive breast carcinomas.
Huang KT; Mikeska T; Dobrovic A; Fox SB
Histopathology; 2010 Sep; 57(3):451-60. PubMed ID: 20727020
[TBL] [Abstract][Full Text] [Related]
11. A novel mode of action of YC-1 in HIF inhibition: stimulation of FIH-dependent p300 dissociation from HIF-1{alpha}.
Li SH; Shin DH; Chun YS; Lee MK; Kim MS; Park JW
Mol Cancer Ther; 2008 Dec; 7(12):3729-38. PubMed ID: 19074848
[TBL] [Abstract][Full Text] [Related]
12. [Growth Regulation of Factor Inhibiting Hypoxia-Inducible Factor in Renal Carcinoma Cells].
Deng S; Yang B; Ren ZJ; Dong Q
Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Jan; 49(1):29-33. PubMed ID: 29737085
[TBL] [Abstract][Full Text] [Related]
13. Substrate requirements of the oxygen-sensing asparaginyl hydroxylase factor-inhibiting hypoxia-inducible factor.
Linke S; Stojkoski C; Kewley RJ; Booker GW; Whitelaw ML; Peet DJ
J Biol Chem; 2004 Apr; 279(14):14391-7. PubMed ID: 14734545
[TBL] [Abstract][Full Text] [Related]
14. High frequency of HIF-1alpha overexpression in BRCA1 related breast cancer.
van der Groep P; Bouter A; Menko FH; van der Wall E; van Diest PJ
Breast Cancer Res Treat; 2008 Oct; 111(3):475-80. PubMed ID: 18030615
[TBL] [Abstract][Full Text] [Related]
15. Ferritin heavy chain controls the HIF-driven hypoxic response by activating the asparaginyl hydroxylase FIH.
Jin P; Kang J; Lee MK; Park JW
Biochem Biophys Res Commun; 2018 May; 499(3):475-481. PubMed ID: 29580991
[TBL] [Abstract][Full Text] [Related]
16. Expression of hypoxia-inducible factor 1 alpha and its downstream targets in fibroepithelial tumors of the breast.
Kuijper A; van der Groep P; van der Wall E; van Diest PJ
Breast Cancer Res; 2005; 7(5):R808-18. PubMed ID: 16168127
[TBL] [Abstract][Full Text] [Related]
17. Regulation of Transactivation at C-TAD Domain of HIF-1
Rani S; Roy S; Singh M; Kaithwas G
Oxid Med Cell Longev; 2022; 2022():2407223. PubMed ID: 35592530
[TBL] [Abstract][Full Text] [Related]
18. Nutlin-3, an Hdm2 antagonist, inhibits tumor adaptation to hypoxia by stimulating the FIH-mediated inactivation of HIF-1alpha.
Lee YM; Lim JH; Chun YS; Moon HE; Lee MK; Huang LE; Park JW
Carcinogenesis; 2009 Oct; 30(10):1768-75. PubMed ID: 19696166
[TBL] [Abstract][Full Text] [Related]
19. Ankyrin Repeat Proteins of Orf Virus Influence the Cellular Hypoxia Response Pathway.
Chen DY; Fabrizio JA; Wilkins SE; Dave KA; Gorman JJ; Gleadle JM; Fleming SB; Peet DJ; Mercer AA
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795413
[TBL] [Abstract][Full Text] [Related]
20. Inverse solvent isotope effects arising from substrate triggering in the factor inhibiting hypoxia inducible factor.
Hangasky JA; Saban E; Knapp MJ
Biochemistry; 2013 Mar; 52(9):1594-602. PubMed ID: 23351038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
